Ignite Creation Date:
2024-05-05 @ 11:46 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00121095
Status:
UNKNOWN
Last Update Posted:
2007-12-21
First Post:
2005-07-13
Brief Title:
Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer
Sponsor:
Cytogen Corporation
Organization:
Cytogen Corporation
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Prostatic Neoplasms |
Keywords:
| Name | View |
|---|---|
| prostate cancer | View |